First! Review of Diclofenac Sodium Sustained Release Tablets
Time of Update: 2020-01-19
The original product of the drug is diclofenac sodium sustained-release tablets (0.1g) of Novartis, with the trade name of "Voltaren".
Application for marketing of diclofenac, the original diabetes drug of microchip biology, was accepted
Time of Update: 2019-09-20
Shenzhen September 19, 2019 / Meitong news agency / -- in September 19, 2019, the application for listing (NDA) of class 1 original new drug, chiglitazar sodium (trade name
college entrance examination, requiring the top 0.1% of the province
Time of Update: 2019-03-25
The US Food and Drug Administration (FDA) has approved sunosi for the treatment of daytime excessive sleepiness (EDS) associated with narcolepsy or obstructive sleep apnea (OSA) in adult patients, jazz pharmaceutical company announced recently.
Lingkang pharmaceutical acquired Hainan cancer hospital assets with a revenue of 0.1 billion yuan
Time of Update: 2018-08-31
[China Pharmaceutical network enterprise news] recently, Lingkang pharmaceutical, a listed company, announced a plan to acquire part of the equity of Chengmei International Medical
US FDA approved Daphne (0.1%) as an over-the-counter drug for acne (acne)
Time of Update: 2016-07-11
Daphne (0.1%) is the first over-the-counter drug for external use of retinoids to treat acne.
FDA approves Stiefel Fabior (0.1%)
Time of Update: 2012-05-14
Source: Stiefel, a subsidiary of China pharmaceutical promotion association 2012-05-14 GlaxoSmithKline Co, said on Friday that the US Food and Drug Administration had approved Fabior (0.1%) new drug application.